×
Don't Miss Out!
Get your weekly Breakfast Briefing eNewsletter, filled with news, trends, and vital information from DIA!
Back to Agenda
Session 11: Post-Marketing Safety Principles and Spontaneous Case Reporting
Session Chair(s)
Mark Vieder, MBA, RPh
Vice President, Drug Safety and Pharmacovigilance
Biorasi, LLC, United States
This session provides an overview of the principles of safety reporting associated with marketed medicinal products including spontaneous reporting systems.
Have an account?